Statistics for Experience in Transitioning From Parenteral Prostacyclins to Selexipag in Pulmonary Arterial Hypertension.

Total visits

views
Experience in Transitioning From Parenteral Prostacyclins to Selexipag in Pulmonary Arterial Hypertension. 69

Total visits per month

views
December 2023 1
January 2024 0
February 2024 0
March 2024 0
April 2024 0
May 2024 0
June 2024 0

File Visits

views
Experience_in_Transitioning_From_Parenteral.5.pdf 202